NCT02859818

Brief Summary

Introduction: Therapeutic Patient Education (TPE) is the key of the interdisciplinary management of type 1 diabetes for adolescents, favoring their adherence and improving their quality of life and metabolic control. Six pediatric diabetes teams have engaged in action research to build a regional ETP program based on social cognitive theory of Bandura, assuming that the learning strategies of theory, applied in ETP program, should strengthen self-efficacy of adolescents with type 1 diabetes, which could induce an improvement behaviors adherence, quality of life and physiological profile of participants about 6 months post-inclusion in the program. Aims: The main objective is to describe the evolution over 6 months of self-efficacy in a cohort of adolescents with type 1 diabetes who followed a therapeutic education program based on social cognitive theory of Bandura in region PACA (ETPACAP program). Secondary objectives are to describe the evolution of 6 months of glycemic control, behavior of adherence, quality of life and other components of social cognitive theory for this population, to explore the effects of socio-cognitive profile on adherence, quality of life and glycemic control among adolescents with type 1 diabetes followed this program. Method: A prospective multicenter cohort study of adolescents with type 1 diabetes who participated in ETPACAP program, consisting of three components:

  • A quantitative component: collection and analysis of changes over 6 months of self-efficacy, adherence, quality of life and HbA1c levels (ANOVA repeated measures);
  • A qualitative component: interviews with 32 participants at M0, M3 and M6 on the socio-cognitive factors according to Bandura (analysis continues theming);
  • An integrative component, exploring the effects of the components of social cognitive theory on adherence, glycemic control and quality of life of adolescents with type 1 diabetes cohort. Expected results: This research is expected to bring new knowledge about the ETP programs and the adolescent cohort studied to make an improvement and adjustment of educational sessions relevant to the needs and expectations of this population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 9, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

August 9, 2016

Status Verified

August 1, 2016

Enrollment Period

3 years

First QC Date

August 1, 2016

Last Update Submit

August 4, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Self-efficacy evaluated with the 10 items-SEDM

    The self-efficacy will be evaluated with the 10 items-SEDM (Iannotti et al., 2006), translated into French by an adaptation process cross-cultural (linguistic validation and metrology)

    6 months

Secondary Outcomes (4)

  • Adherence will be evaluated using 'the Diabetes Self-Management Profile "tool (DSMP)

    6 months

  • Quality of life will be assessed using the KIDSCREEN-27

    6 months

  • Glycemic control: glycated hemoglobin (HbA1c)

    6 months

  • Outcome expectations, socio-structural factors and personal goals

    6 months

Study Arms (1)

adolescents with type 1 diabetes

OTHER

adolescents with type 1 diabetes following their participation in therapeutic education program

Other: therapeutic education program

Interventions

adolescents with type 1 diabetes

Eligibility Criteria

Age11 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Aged between 11 and 17 years inclusive;
  • Type 1 diabetes diagnosis confirmed by a doctor according to the diagnostic criteria;
  • More than 6 months in the disease;
  • Treatment with insulin for at least 6 months before the educational intervention;
  • Mastery of the French language written (elementary level)
  • Fluency in speaking the French language (elementary level)
  • Consent signed by the holders of parental authority and adolescents.

You may not qualify if:

  • Pregnant women, parturient women or breastfeeding mothers (Article L.1121-5 of the Code of Public Health.)
  • Persons deprived of liberty by a judicial or administrative decision, those hospitalized without consent under articles L. 3212-1 and L. 3213-1 that do not fall under the provisions of Article L. 1121-8 of the Code of Public Health

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hôpitaux de Marseille

Marseille, 13354, France

Location

Study Officials

  • Urielle DESALBRES

    Assistance Publique Hôpitaux de Marseille

    STUDY DIRECTOR

Central Study Contacts

Sébastien COLSON

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2016

First Posted

August 9, 2016

Study Start

December 1, 2016

Primary Completion

December 1, 2019

Study Completion

May 1, 2020

Last Updated

August 9, 2016

Record last verified: 2016-08

Locations